Subscribe to RSS
DOI: 10.1055/s-0039-1681312
ENDOSCOPIC BAND LIGATION WITHOUT RESECTION OF SMALL-SIZED SUBMUCOSAL TUMOURS: RESULTS IN SHORT-MEDIUM FOLLOW-UP TERM OF A MULTICENTER PROSPECTIVE STUDY (BANDING-SMT)
Publication History
Publication Date:
18 March 2019 (online)
Aims:
The endoscopic-band-ligation (EBL) without resection combined with a single-incision-needle-knife (SINK) biopsy is a little reported option in the management of submucosal-tumours (SMT). The main aim was to determine the efficacy of this technique. Secondary aims: to evaluate its safety and the diagnostic yield of biopsy.
Methods:
Prospective multicenter study. Inclusion criteria: SMT≤15 mm, confirmed by endoscopic-ultrasound (EUS). Technical success: complete EBL of the SMT plus SINK biopsy. Clinical success: total disappearance of the SMT. Clinical controls: recovery at first 6-hours, calling at 48-hours and 7-days. EUS control at 4 – 6 weeks and 12 months. Clinical-Trials.gov register: NCT03247231.
Results:
Sixty-four cases (44% of the sample calculation); EUS-control 4 – 6 weeks n = 51. Esophagus n = 3, stomach n = 49, duodenum n = 11, rectum n = 1. SMT medium-size: 9.5-mm (4.5 – 15 mm). EBL technical success: 87.5% (n = 56/64). Clinical success at 4 – 6 weeks: 92.2% (n = 47/51), overall clinical success: 79.7% (n = 47/59). SMT dependence of superficial vs. deep layer subanalysis: technical success 93% vs. 75%; overall clinical success 87% vs. 65%. SMT≤10-mm vs. > 10-mm: technical success 100% vs. 68%; overall clinical success 97% vs. 54%. Pathological diagnosis: 62.5% (30/48); no differences between SMT-size, SMT-layer, or number or biopsies. Two mild adverse events (3%): bleeding, pain. Incidences: epigastralgy (6h: 33%; 24 – 48h: 30%; 7-days: 14%; 4 – 6 weeks: 2%).
Superficial layer |
Deep layer |
SMT ≤10-mm |
SMT > 10-mm |
|
YES technical success |
41 (93%) |
15 (75%) |
39 (100%) |
17 (68%) |
NO technical success |
3 (7%) |
5 (25%) |
0 (0%) |
8 (32%) |
YES clinical success |
34 (94%) |
13 (87%) |
34 (97%) |
13 (81%) |
Overall NO clinical success |
5 (13%) |
7 (35%) |
1 (3%) |
11 (46%) |
Conclusions:
Preliminary results in the short-medium follow-up term indicate that EBL of small SMT, supplemented with SINK biopsy, seems to be a feasible and safe technique. The limitations of its technical and clinical success seem to be associated with the SMT size and deep layers dependence.